These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11097051)

  • 21. Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotides.
    Duca M; Guianvarc'h D; Oussedik K; Halby L; Garbesi A; Dauzonne D; Monneret C; Osheroff N; Giovannangeli C; Arimondo PB
    Nucleic Acids Res; 2006; 34(6):1900-11. PubMed ID: 16598074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.
    Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M
    Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and binding properties of oligo-2'-deoxyribonucleotides conjugated with triple-helix-specific intercalators: benzo[e] and benzo[g] pyridoindoles.
    Vinogradov S; Roig V; Sergueeva Z; Nguyen CH; Arimondo P; Thuong NT; Bisagni E; Sun JS; Hélène C; Asseline U
    Bioconjug Chem; 2003; 14(1):120-35. PubMed ID: 12526701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of a degenerate consensus sequence to quantify recognition sites by vertebrate DNA topoisomerase II.
    Spitzner JR; Muller MT
    J Mol Recognit; 1989 Sep; 2(2):63-74. PubMed ID: 2561527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
    Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
    Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of yeast DNA topoisomerase II mutants resistant to the antitumor drug amsacrine.
    Wasserman RA; Wang JC
    Cancer Res; 1994 Apr; 54(7):1795-800. PubMed ID: 8137294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA sequence preferences at sites cleaved by human DNA topoisomerase II in response to novel quinolone derivatives.
    Huff AC; Robinson RG; Evans AC; Selander KN; Wentland MP; Rake JB; Coughlin SA
    Anticancer Drug Des; 1995 Apr; 10(3):251-76. PubMed ID: 7748459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting topoisomerase I cleavage to specific sequences of DNA by triple helix-forming oligonucleotide conjugates. A comparison between a rebeccamycin derivative and camptothecin.
    Arimondo PB; Bailly C; Boutorine A; Sun JS; Garestier T; Hélène C
    C R Acad Sci III; 1999 Sep; 322(9):785-90. PubMed ID: 10547719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinolone action against human topoisomerase IIalpha: stimulation of enzyme-mediated double-stranded DNA cleavage.
    Bromberg KD; Burgin AB; Osheroff N
    Biochemistry; 2003 Apr; 42(12):3393-8. PubMed ID: 12653542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4'-(9-acridinylamino)methane-sulfon-m-anisidide.
    DeVore RF; Corbett AH; Osheroff N
    Cancer Res; 1992 Apr; 52(8):2156-61. PubMed ID: 1313738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of triple-helix-directed DNA cleavage by benzoquinoquinoxaline-ethylenediaminetetraacetic acid conjugates.
    Zain R; Polverari D; Nguyen CH; Blouquit Y; Bisagni E; Garestier T; Grierson DS; Sun JS
    Chembiochem; 2003 Sep; 4(9):856-62. PubMed ID: 12964160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517.
    Gupta M; Abdel-Megeed M; Hoki Y; Kohlhagen G; Paull K; Pommier Y
    Mol Pharmacol; 1995 Oct; 48(4):658-65. PubMed ID: 7476891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides.
    Hélène C
    Anticancer Drug Des; 1991 Dec; 6(6):569-84. PubMed ID: 1772570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solution conformation of the (-)-cis-anti-benzo[a]pyrenyl-dG adduct opposite dC in a DNA duplex: intercalation of the covalently attached BP ring into the helix with base displacement of the modified deoxyguanosine into the major groove.
    Cosman M; Hingerty BE; Luneva N; Amin S; Geacintov NE; Broyde S; Patel DJ
    Biochemistry; 1996 Jul; 35(30):9850-63. PubMed ID: 8703959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence-specific alkylation and cleavage of DNA mediated by purine motif triple helix formation.
    Grant KB; Dervan PB
    Biochemistry; 1996 Sep; 35(38):12313-9. PubMed ID: 8823165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between topoisomerase II inhibition, sequence-specificity and DNA binding mode of dicationic diphenylfuran derivatives.
    Bailly C; Dassonneville L; Carrasco C; Lucas D; Kumar A; Boykin DW; Wilson WD
    Anticancer Drug Des; 1999 Feb; 14(1):47-60. PubMed ID: 10363027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of site-specific topoisomerase II-mediated DNA cleavage by an N-methylpyrrolecarboxamide-anilinoacridine conjugate: relation to DNA binding.
    Fossé P; René B; Saucier JM; Hénichart JP; Waring MJ; Colson P; Houssier C; Bailly C
    Biochemistry; 1994 Aug; 33(33):9865-74. PubMed ID: 8060993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization of an aminoacridine antitumor agent in a type II topoisomerase-DNA complex.
    Freudenreich CH; Kreuzer KN
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11007-11. PubMed ID: 7971998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thioguanine substitution alters DNA cleavage mediated by topoisomerase II.
    Krynetskaia NF; Cai X; Nitiss JL; Krynetski EY; Relling MV
    FASEB J; 2000 Nov; 14(14):2339-44. PubMed ID: 11053256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel trifluoromethylated 9-amino-3,4-dihydroacridin-1(2H)-ones act as covalent poisons of human topoisomerase IIα.
    Infante Lara L; Sledge A; Laradji A; Okoro CO; Osheroff N
    Bioorg Med Chem Lett; 2017 Feb; 27(3):586-589. PubMed ID: 27998679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.